RxDoctor Payments Data

Shirley Seward

Family · Easton, MDNPI 1184771966

Payments from drug & device makers

$1,029in general payments, 2019–2025

Across 46 payments — averaging $22.36 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Pfizer$120
  • Lilly USA, LLC$113
  • Astellas Pharma US Inc$95
  • Amgen$92
  • AbbVie$87
  • Merck$85
  • plus $437 from 11 others

What the payments were for

  • Food & beverage$1,029100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$1,029 in reported general payments places this provider in the 70th percentile of 2,843 family providers in Maryland.

See all family providers in Maryland

Medicare billing

Part B allowed, 2024
$137,376
Medicare patients
702
Services billed
2,062

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Actemra ActpenTocilizumab14$61,802
EliquisApixaban49$40,586
JardianceEmpagliflozin20$31,208
MyrbetriqMirabegron38$21,386
XareltoRivaroxaban18$17,230
OzempicSemaglutide12$10,970
Trelegy ElliptaFluticasone/Umeclidin/Vilanter17$10,183
EntrestoSacubitril/Valsartan14$9,444
Atorvastatin Calcium345$4,416
Rosuvastatin Calcium180$4,410
Basaglar Kwikpen U-100Insulin Glargine,hum.Rec.Anlog15$3,329
Levothyroxine Sodium298$3,006
Gabapentin155$2,546
SynthroidLevothyroxine Sodium33$2,492
Memantine Hcl20$2,354

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
PfizerEliquis$120$40,58649 claims
Boehringer IngelheimJardiance$67$31,20820 claims
Astellas Pharma US IncMyrbetriq$95$21,38638 claims
GSKTrelegy Ellipta$59$10,18317 claims
AbbVieSynthroid$87$2,49233 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 70th percentile of 2,843 family providers in Maryland.

Other family in Easton

See the full list for Maryland

Where these figures come from

Is this you, or does something look wrong? →